Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder - Related Studies

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

This study is currently recruiting participants.

Study NCT00489515. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer
		Gallbladder Cancer
		Gastric Cancer
		Pancreatic Cancer
		Small Intestine Cancer

2	Additional conditions recognized in this trial
		Colorectal Neoplasms
		Duodenal Neoplasms
		Gallbladder Neoplasms
		Ileal Neoplasms
		Intestinal Neoplasms
		Jejunal Neoplasms
		Pancreatic Neoplasms
		Stomach Neoplasms

3	More general conditions related to this trial
		Biliary Tract Diseases
		Biliary Tract Neoplasms
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Duodenal Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gallbladder Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Ileal Diseases
		Intestinal Diseases
		Jejunal Diseases
		Neoplasms
		Neoplasms by Site
		Pancreatic Diseases
		Rectal Diseases
		Stomach Diseases

4	Interventions listed in this trial
		isosulfan blue
		conventional surgery
		laboratory biomarker analysis
		lymphadenectomy
		lymphangiography
		sentinel lymph node biopsy

5	Sponsors listed in this trial
		Wake Forest University
		National Cancer Institute (NCI)